AbCellera Biologics (NASDAQ:ABCL) is working to evolve from a technology-enabled drug discovery partner into what the company ...

India’s ₹10,000 crore Biopharma SHAKTI scheme marks a definitive shift from low-cost generics to high-value biologics, aiming ...

In the new subcutaneous drug delivery landscape, the growing trend towards patient-friendly, at-home administration is ...

To support growing demand, Jetour Malaysia is also expanding its dealership and service network nationwide. The company ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Security must be addressed at the platform level to ensure every security-relevant chiplet has an identity that can be ...

From rare earth metals to nuclear propulsion, five companies are rebuilding the defense supply chain the Pentagon neglected ...

The King Fahd Causeway is a critical 25km economic and logistics corridor linking Saudi Arabia and Bahrain ...

New Zealand-born Wilson's term was due to end in 2027 but he is currently reportedly serving a six-month notice period ...

As the resident tech reporter for The Wall Street Journal’s Stockholm bureau, Sven has been covering both established regional behemoths, such former phone giant Nokia Corp. and mobile network ...